Literature DB >> 23169723

Small renal oncocytomas: is segmental enhancement inversion a characteristic finding at biphasic MDCT?

Martin E O'Malley1, Phil Tran, Anthony Hanbidge, Patrik Rogalla.   

Abstract

OBJECTIVE: The purpose of this study was to retrospectively determine whether segmental enhancement inversion was a common and characteristic finding in small (≤ 4 cm) renal oncocytomas on biphasic contrast-enhanced CT.
MATERIALS AND METHODS: This retrospective case-control study included 16 patients with 16 renal oncocytomas and 15 control patients with 15 renal cell carcinomas (RCCs), matched for age and sex, who underwent biphasic contrast-enhanced MDCT at our institution. Three reviewers independently analyzed each tumor for enhancement patterns on MDCT, including the presence or absence of segmental enhancement inversion, homogeneity, and phase of peak enhancement.
RESULTS: The mean and median sizes of the oncocytomas were 2.5 and 2.4 cm, respectively (range, 1.1-3.9 cm), and the mean and median sizes of the RCCs were both 2.6 cm (range, 1.4-3.9 cm). There was no significant difference in the size of the renal masses between the two groups (p = 0.50). For two reviewers, segmental enhancement inversion was not present in any of the renal masses; for one reviewer, segmental enhancement inversion was present in one oncocytoma (6%) and one RCC (7%). For all reviewers, there was no feature or enhancement pattern that was statistically significantly associated with renal oncocytoma or RCC (p < 0.05).
CONCLUSION: Segmental enhancement inversion was not a common or characteristic CT finding for renal oncocytoma and was not helpful in differentiating small renal oncocytomas from RCC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23169723     DOI: 10.2214/AJR.12.8616

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

1.  Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI).

Authors:  Nicola Schieda; Maali Al-Subhi; Trevor A Flood; Mohammed El-Khodary; Matthew D F McInnes
Journal:  Eur Radiol       Date:  2014-07-17       Impact factor: 5.315

Review 2.  Solid renal masses: what the numbers tell us.

Authors:  Stella K Kang; William C Huang; Pari V Pandharipande; Hersh Chandarana
Journal:  AJR Am J Roentgenol       Date:  2014-06       Impact factor: 3.959

Review 3.  Diagnostic accuracy of segmental enhancement inversion for diagnosis of renal oncocytoma at biphasic contrast enhanced CT: systematic review.

Authors:  Nicola Schieda; Matthew D F McInnes; Lilly Cao
Journal:  Eur Radiol       Date:  2014-03-26       Impact factor: 5.315

Review 4.  CT and MRI of small renal masses.

Authors:  Zhen J Wang; Antonio C Westphalen; Ronald J Zagoria
Journal:  Br J Radiol       Date:  2018-05-10       Impact factor: 3.039

Review 5.  MRI phenotype in renal cancer: is it clinically relevant?

Authors:  Naomi Campbell; Andrew B Rosenkrantz; Ivan Pedrosa
Journal:  Top Magn Reson Imaging       Date:  2014-04

6.  Imaging spectrum of renal oncocytomas: a pictorial review with pathologic correlation.

Authors:  Kousei Ishigami; Aaron R Jones; Laila Dahmoush; Leandro V Leite; Marius G Pakalniskis; Thomas J Barloon
Journal:  Insights Imaging       Date:  2014-12-14

7.  Diagnostic potential of multidetector computed tomography for characterizing small renal masses.

Authors:  Maria Elisabetta Mancini; Annamaria Albergo; Marco Moschetta; Mariacristina Angelelli; Arnaldo Scardapane; Giuseppe Angelelli
Journal:  ScientificWorldJournal       Date:  2015-04-09

Review 8.  Imaging findings of common benign renal tumors in the era of small renal masses: differential diagnosis from small renal cell carcinoma: current status and future perspectives.

Authors:  Sungmin Woo; Jeong Yeon Cho
Journal:  Korean J Radiol       Date:  2015-01-09       Impact factor: 3.500

Review 9.  Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer.

Authors:  Francesco Trevisani; Matteo Floris; Roberto Minnei; Alessandra Cinque
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.